Linda Mihalov, MD
Obstetrics & Gynecology · Seattle, WANPI 1730273244
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $257 of the $307 with a category attached, or 83.7%. 4 manufacturers reported payments, led by Applied Medical Resources Corporation at 48.3% of the total. Reporting peaked in 2022 at $148 and has fallen 83.9% since, to $24 in 2024.
Across 5 payments — averaging $61.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$148
- Gynesonics, Inc.$95
- Intuitive Surgical$40
- Hologic Sales And Service, LLC$24
Across 29 payments — averaging $3978.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$115K
- Gynesonics, Inc.$780
What the payments were for
- Travel & lodging$5016%
- Food & beverage$25784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 2 | $148 |
| Gynesonics, Inc. | 1 | $95 |
| Intuitive Surgical | 1 | $40 |
| Hologic Sales And Service, LLC | 1 | $24 |
How this compares
$307 in reported general payments places this provider in the 60th percentile of 733 obstetrics & gynecology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 113 | $13,249 |
| Estradiol (Twice Weekly)Estradiol | 36 | $3,360 |
| DottiEstradiol | 11 | $1,061 |
| Betamethasone Diprop AugmentedBetamethasone Dipropionate | 13 | $964 |
| ProgesteroneProgesterone, Micronized | 14 | $306 |
| Clobetasol Propionate | 16 | $239 |
| ValacyclovirValacyclovir Hcl | 11 | $231 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Seattle
- Joshua PressSeattle$115K
- Ashley FullerSeattle$57K
- Katherine DebiecSeattle$31K
- Susan ReedSeattle$17K
- Ying LiuSeattle$8K
- Linda EckertSeattle$7K
- Jessie MarrsSeattle$4K
- James MillerSeattle$4K
- Dilys WalkerSeattle$4K
- Carolyn KayEdmonds$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.